GlaxoSmithKline Q1 net down 63% at Rs 26 cr on GST transition

The company had posted a net profit of Rs 72.27 crore for the same period of the previous fiscal

Smoking doesn't relax, it may increase sensitivity to social stress: Study

Last Updated : Jul 25 2017 | 6:50 PM IST

GlaxoSmithKline Pharmaceuticals on Tuesday reported 63.44 per cent decline in standalone net profit to Rs 26.42 crore for the first quarter ended June 30, mainly on account of trade destocking due to transition into GST.

The company had posted a net profit of Rs 72.27 crore for the same period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.

"Sales revenue of the pharmaceuticals business declined 14.2 per cent during the quarter ended June 30, 2017 as compared to the corresponding quarter of the previous year," GlaxoSmithKline said.

GlaxoSmithKline Pharma Q3 profit dips 33 per cent at Rs 53 crore

Asian Paints Q1 net down 20% at Rs 441 cr, on GST rollout, higher expenses

Avenue Supermarts Q1 net results up 48% at Rs 174.77 crore

RIL's Q1 net profit up 28% at Rs 9,108 cr on better refining, petchem biz

UltraTech Cement Q1 net profit up 15% to Rs 898 crore

Sales were adversely impacted by an estimated Rs 130 crore in the quarter as a consequence of trade destocking due to transition into GST, it added.

Standalone total revenue from operations stood at Rs 607.09 crore for the quarter under consideration, as against Rs 705.33 crore for the corresponding period a year ago.

Shares of GlaxoSmithKline today closed at Rs 2,510.05 per scrip on BSE, down 1.80 per cent from its previous close.

Already subscribed? Log in

Subscribe to read the full story →

^*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

In-depth market analysis & insights with access to The Smart Investor

Ad-free Reading

Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

Access Business Standard across devices — mobile, tablet, or PC, via web or app